ExScale Biospecimen Solutions AB is a Swedish AB, operating in the Other research and experimental development on natural sciences and engineering sector. Incorporated in 2012, the company has 3 employees and reported revenue of SEK 1.0m in its latest annual filing.
Bolaget skall bedriva utveckling, tillverkning och försäljning av utrustning, reagens och tjänster för extraktion av nukleinsyror samt därmed förenlig verksamhet.
(no translation available)
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
In its most recent annual report (2018), ExScale Biospecimen Solutions AB reported revenue of SEK 1.0m, a decrease of 15% on the year before. The figures on this page draw on 4 annual filings covering 2015 to 2018. The bottom line showed a net loss of SEK 10.6m, and the EBITDA margin stood at -709.8%.
At the end of 2018, equity financed 52.4% of the balance sheet, and current assets covered short-term debt 2.8 times.
Frequently asked questions
What is the Org number of ExScale Biospecimen Solutions AB?
ExScale Biospecimen Solutions AB is registered with Bolagsverket / SCB under Org 5568926090.
What is the revenue of ExScale Biospecimen Solutions AB?
ExScale Biospecimen Solutions AB reported revenue of SEK 1.0m in 2018.
How many employees does ExScale Biospecimen Solutions AB have?
ExScale Biospecimen Solutions AB employs 3 people as of the latest annual report.
Who is the chairman of ExScale Biospecimen Solutions AB?
Carl Tobias Sjöblom chairs the board of ExScale Biospecimen Solutions AB, in role since 2022.
